Pulmatrix, Inc. PULM
Set alert
1.40 USD -0.02 -1.41%
At close · Oct 30
1.40 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.35 Day range 1.45
1.16 52-week range 4.99
- YTD
- -37.22%
- 1 year
- -71.66%
- Open
- 1.41
- Prev close
- 1.42
- Mkt cap
- 5.11M
- Vol
- 9.19K
- Avg vol
- 26.50K
- EPS
- -1.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.35
- High
- 1.45
- Forward P/E
- -1.28
- Beta
- 0.99
- Short ratio
- 0.75
- Inst. own
- 7.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.18
- 200-d avg
- 2.54
- 1y target
- 0.00
News
2 days ago globenewswire.com
Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study
Interim Results in Super-Aged Rats Tested Externally Show Preserved Motor Performance and Reduced Fat Mass, Consistent with Prior Findings in Aged Mice Tested at Eos's R&D Facility; Data Support…
-
1 week ago benzinga.com
Eos SENOLYTIX Presents New Preclinical Survival, Healthspan, Mechanism-Of-Action Data For Its PTC-2105 Candidate At 17th World Congress On Targeting Mitochondria 2026
Eos SENOLYTIX, Inc. ("Eos" or the "Company") a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today presented new preclinical survival, healthspan and